BRPI0918985A2 - derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina - Google Patents

derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina

Info

Publication number
BRPI0918985A2
BRPI0918985A2 BRPI0918985A BRPI0918985A BRPI0918985A2 BR PI0918985 A2 BRPI0918985 A2 BR PI0918985A2 BR PI0918985 A BRPI0918985 A BR PI0918985A BR PI0918985 A BRPI0918985 A BR PI0918985A BR PI0918985 A2 BRPI0918985 A2 BR PI0918985A2
Authority
BR
Brazil
Prior art keywords
isoxazol
dopamine
benzo
receptor modulators
derivatives useful
Prior art date
Application number
BRPI0918985A
Other languages
English (en)
Inventor
Georg Jaeschke
Luca Gobbi
Lucinda Steward
Rosa Maria Rodriguez Sarmiento
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0918985A2 publication Critical patent/BRPI0918985A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0918985A 2008-09-23 2009-09-15 derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina BRPI0918985A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08164903 2008-09-23
PCT/EP2009/061906 WO2010034646A1 (en) 2008-09-23 2009-09-15 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors

Publications (1)

Publication Number Publication Date
BRPI0918985A2 true BRPI0918985A2 (pt) 2015-12-01

Family

ID=41210461

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918985A BRPI0918985A2 (pt) 2008-09-23 2009-09-15 derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina

Country Status (12)

Country Link
US (1) US7939535B2 (pt)
EP (1) EP2344482B1 (pt)
JP (1) JP2012502947A (pt)
KR (1) KR20110059649A (pt)
CN (1) CN102164914A (pt)
AU (1) AU2009296045B2 (pt)
BR (1) BRPI0918985A2 (pt)
CA (1) CA2736724A1 (pt)
ES (1) ES2391712T3 (pt)
IL (1) IL211572A0 (pt)
MX (1) MX2011002752A (pt)
WO (1) WO2010034646A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000032987A (ja) * 1998-07-16 2000-02-02 Dai Ichi Seiyaku Co Ltd Dna
EP2337783A1 (en) * 2008-09-23 2011-06-29 F. Hoffmann-La Roche AG Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors
US8586579B2 (en) 2010-06-21 2013-11-19 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8470828B2 (en) * 2010-07-06 2013-06-25 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) * 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
CN104140421B (zh) * 2013-05-08 2017-04-05 上海医药工业研究院 苯并异噻唑类化合物及在制备抗精神分裂症药物中的应用
WO2017045599A1 (zh) * 2015-09-15 2017-03-23 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
CN106518841B (zh) 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
BR112020014875A2 (pt) 2018-01-26 2020-12-08 Shionogi & Co., Ltd. Composto cíclico condensado tendo antagonismo de receptor de dopamina d3
WO2019146740A1 (ja) 2018-01-26 2019-08-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する環式化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
CN1187192A (zh) * 1995-06-06 1998-07-08 赫彻斯特马里恩鲁斯公司 作为抗精神病剂的苯并异噁唑和吲唑衍生物
FR2749304B1 (fr) * 1996-06-04 1998-06-26 Adir Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE412638T1 (de) * 2001-02-16 2008-11-15 Aventis Pharma Inc Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
AU2003263413A1 (en) * 2002-09-17 2004-04-08 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
EP2337783A1 (en) * 2008-09-23 2011-06-29 F. Hoffmann-La Roche AG Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors

Also Published As

Publication number Publication date
JP2012502947A (ja) 2012-02-02
AU2009296045A1 (en) 2010-04-01
AU2009296045B2 (en) 2013-07-04
US20100075985A1 (en) 2010-03-25
WO2010034646A1 (en) 2010-04-01
EP2344482A1 (en) 2011-07-20
MX2011002752A (es) 2011-04-07
IL211572A0 (en) 2011-05-31
CN102164914A (zh) 2011-08-24
ES2391712T3 (es) 2012-11-29
EP2344482B1 (en) 2012-08-15
US7939535B2 (en) 2011-05-10
KR20110059649A (ko) 2011-06-02
CA2736724A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
BRPI1009200A2 (pt) derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda
BRPI1012770A2 (pt) derivados de tiofeno
BRPI0911243A2 (pt) derivados de benzofurano, benzotiofeno, benzotiazol como moduladores de fxr
BRPI0910585A2 (pt) indóis como moduladores de receptor de aceticolina nicotínica do subtipo alfa-7
PT2860179T (pt) Derivados de pirazolo-piridina como inibidores de nadph-oxidase
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
BR112013015260A2 (pt) derivados de enxofre como moduladores de receptor de quimiocina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0910607A2 (pt) derivados do ciclohexano espirocíclicos substituídos
CU23870B1 (es) Derivados de ciclopropilamida como moduladores h3
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0809930A2 (pt) Derivados de carboxamida imidazolidina como moduladores de p2x7
BRPI0918064A2 (pt) distribuidor de substância
IL211572A0 (en) Benzo[d] isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
BRPI0915991A2 (pt) derivados de sulfamida substituída
BRPI0822058A2 (pt) Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7
BRPI0912234A2 (pt) derivados de salinosporamida como inibidores de proteassomas
EP2239253A4 (en) NOVEL PHENYLPYRROL DERIVATIVE
BR112013023914A2 (pt) derivados de benzo [b] [1,4] oxazina como moduladores de receptor sensor de cálcio
BRPI0914942A2 (pt) Compostos de oxindol
IL210067A0 (en) Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0922652A2 (pt) Derivados de quinazolinamida
BR112013013037A2 (pt) derivados de indol como moduladores dos receptores de s1p
BRPI0920247A2 (pt) benzimidazóis heterocíclicos como moduladores de trpm8.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2376 DE 19-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.